Article
Evolution toward extremely high imipenem resistance in Mycobacterium abscessus outbreak strains
10 Sept 2024
Abstract excerpt
ABSTRACT Treatment of Mycobacterium abscessus pulmonary disease requires multiple antibiotics including intravenous β-lactams (e.g., imipenem). M. abscessus produces a β-lactamase (Bla Mab ) that inactivates β-lactam drugs but less efficiently carbapenems. Due to intrinsic and acquired resistance in M. abscessus and poor clinical outcomes, it is critical to understand the development of antibiotic resistance both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
